APPLICATION
ANDA074648
TYPE
ANDA
ORIGINAL APPROVAL
1997-03-18
LATEST ACTION
1999-11-01
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
LORAZEPAMDiscontinued
LORAZEPAM 0.5MG/5ML · SOLUTION · ORAL
Approval history
1999-11-01Manufacturing (CMC) · Supplement 4AP
1999-08-18Manufacturing (CMC) · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.